Randomise the next line of treatment before the first one fails

Sequencing questions are almost never answered because patients leave the trial at progression. A pre-randomised design assigns the second-line option at the time of first-line enrolment, keeps patients within the protocol at progression, and collects the progression biopsy. Total sample size increases modestly, but the design yields a real strategy comparison rather than isolated line-by-line results.